Discover
KZIA
Kazia Therapeutics Limited
13.39
2 x 10.48
2 x 17.33
bid
ask
-
0.69
4.90%
2 @ 04:00 PM
13.47 +0.08 (0.60%)
| Ytd | 94.34% | |
| 1y | 103.50% |
13.39
day range
14.81
4.86
52 week range
17.40
| Open | 14.78 | Prev Close | 14.08 | Low | 13.39 | High | 14.81 | Mkt Cap | 153.01M |
| Vol | 135.61K | Avg Vol | 225.10K | EPS | -7.33 | P/E | N/A | Forward P/E | N/A |
| Beta | 2.08 | Short Ratio | 0.11 | Inst. Own | 7.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-29 | 50-d Avg | 12.98 | 200-d Avg | 9.15 | 1yr Est | 19.15 |
KZIA News
benzinga.com
BTIG Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $34
BTIG analyst Kambiz Yazdi initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy ratin
benzinga.com
Lake Street Initiates Coverage On Kazia Therapeutics with Buy Rating, Announces Price Target of $32
Lake Street initiates coverage on Kazia Therapeutics (NASDAQ:KZIA) with a Buy rating and announces
benzinga.com
Kazia Therapeutics Appoints James Levine As CFO, Effective June 1
Mr. Levine brings more than two decades of experience across investment banking, executive and finan